Literature DB >> 2581099

A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass.

R M Sade, M R Stroud, F A Crawford, J M Kratz, J P Dearing, D M Bartles.   

Abstract

The ideal priming fluid for cardiopulmonary bypass is not known. We designed a study to determine whether there are important differences in the clinical effects of hydroxyethyl starch versus albumin when used in priming fluid, and in the clinical effects of colloid versus crystalloid priming fluid. We prospectively randomized 83 adult patients undergoing coronary artery bypass or valve replacement. All patients were managed by standardized protocol, and they received one of three priming fluids for bypass: hydroxyethyl starch (HES), 26 patients; albumin (ALB), 28 patients, and lactated Ringer's solution (LRS), 29 patients. The groups were stratified by body weight and type of operation. We measured 41 variables relating to operative time factors, fluid balance, bleeding, and organ function (renal, cardiac, and pulmonary) at several time intervals. The LRS group had a significantly lower colloid osmotic pressure than the other two groups, and the HES group had a substantially higher blood viscosity. Although the prothrombin time was significantly lower in the LRS group (p less than 0.05), the differences were very small and not clinically important. The platelet count in the HES group was significantly lower than in the other two groups immediately after bypass, but it was not different by the time the patients left the operating room. There were no differences among the groups in chest tube drainage, blood bank usage, or fluid balance. Postoperatively, the pulmonary shunt fraction was significantly greater in the LRS group. Body weight increased more in the LRS than in the HES and ALB groups (p = 0.01). No adverse reaction to the prime solutions was noted. The differences between the HES and ALB groups--prothrombin time, platelet count, and blood viscosity--had no apparent clinical effects; thus, the two may be considered clinically equivalent. The greater somatic and pulmonary fluid accumulation in the LRS group suggests that colloid is preferable to crystalloid in priming fluid.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581099

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

Review 1.  Hydroxyethyl starch for cardiovascular surgery: a systematic review of randomized controlled trials.

Authors:  Xue-Yin Shi; Zui Zou; Xing-Ying He; Hai-Tao Xu; Hong-Bin Yuan; Hu Liu
Journal:  Eur J Clin Pharmacol       Date:  2011-03-02       Impact factor: 2.953

2.  A comparison between 25% albumin and 6% hydroxyethyl starch solutions on lung water accumulation during and immediately after cardiopulmonary bypass.

Authors:  P D Lumb
Journal:  Ann Surg       Date:  1987-08       Impact factor: 12.969

3.  Comparison of Albumin, Hydroxyethyl Starch and Ringer Lactate Solution as Priming Fluid for Cardiopulmonary Bypass in Paediatric Cardiac Surgery.

Authors:  Jigar Patel; Mrugesh Prajapati; Atul Solanki; Himani Pandya
Journal:  J Clin Diagn Res       Date:  2016-06-01

Review 4.  Use of plasma volume expanders in myocardial revascularisation.

Authors:  J H Lacy; C B Wright
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

Review 5.  The appropriate role of colloids in managing fluid imbalance: a critical review of recent meta-analytic findings.

Authors:  A R Webb
Journal:  Crit Care       Date:  2000-10-13       Impact factor: 9.097

Review 6.  Fluid management: the pharmacoeconomic dimension.

Authors:  J L Vincent
Journal:  Crit Care       Date:  2000-10-13       Impact factor: 9.097

Review 7.  Albumin in adult cardiac surgery: a narrative review.

Authors:  Ciara Hanley; Jeannie Callum; Keyvan Karkouti; Justyna Bartoszko
Journal:  Can J Anaesth       Date:  2021-04-21       Impact factor: 6.713

8.  Fluid resuscitation practices in cardiac surgery patients in the USA: a survey of health care providers.

Authors:  Solomon Aronson; Paul Nisbet; Martin Bunke
Journal:  Perioper Med (Lond)       Date:  2017-10-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.